Market Tracker

10/23 5:49am ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.45
Data as of Oct 22
 -0.03 / -2.03%
Today’s Change
1.16
Today|||52-Week Range
3.18
+4.32%
Year-to-Date

Today’s Trading

Previous close1.48
Today’s open1.48
Day’s range-- - --
Volume507,967
Average volume (3 months)1,070,784
Market cap$265.7M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-37.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book3.91

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...-0.13-4.56%
POZNPOZEN Inc+0.20+2.42%
ZIOPZIOPHARM Oncology In...+0.03+1.18%
AMBIAmbit Biosciences Co...-0.17-1.08%
Data as of 10/22/2014

Financials

Next reporting dateDecember 11, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts